Choi JH et al. |
[Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid]. |
2016 |
Korean J Gastroenterol |
pmid:27206439
|
Norrholm SD et al. |
Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. |
2016 |
Behav Res Ther |
pmid:27183343
|
Meuret AE et al. |
The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. |
2016 |
Behav Res Ther |
pmid:27070526
|
Desjardins CA et al. |
Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. |
2016 |
Nat. Genet. |
pmid:27064254
|
Minshawi NF et al. |
A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders. |
2016 |
Mol Autism |
pmid:26770664
|
Otto MW et al. |
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions. |
2016 |
Biol. Psychiatry |
pmid:26520240
|
Schade S and Paulus W |
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review. |
2016 |
Int. J. Neuropsychopharmacol. |
pmid:26364274
|
Housman ST et al. |
Isolation and quantitation of Clostridium difficile in aqueous and fecal matter using two types of selective media. |
2016 |
J Microbiol Immunol Infect |
pmid:26198865
|
Rapee RM et al. |
d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders. |
2016 |
Behav Res Ther |
pmid:27771572
|
Hu P et al. |
Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects. |
2016 |
J. Neurosci. Res. |
pmid:27638600
|
Mikulka CR and Sands MS |
Treatment for Krabbe's disease: Finding the combination. |
2016 |
J. Neurosci. Res. |
pmid:27638598
|
Ortiz V et al. |
Effect of a positive reinforcing stimulus on fear memory reconsolidation in ethanol withdrawn rats: Influence of d-cycloserine. |
2016 |
Behav. Brain Res. |
pmid:27522017
|
Prasad R et al. |
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis. |
2016 |
Indian J Tuberc |
pmid:27451820
|
Sartori SB et al. |
Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches. |
2016 |
Int. J. Neuropsychopharmacol. |
pmid:26625894
|
Malan-Müller S et al. |
Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq. |
2016 |
Metab Brain Dis |
pmid:26400817
|
Sierra RO et al. |
Medial orbitofrontal cortex lesion prevents facilitatory effects of d-cycloserine during fear extinction. |
2016 |
Behav. Brain Res. |
pmid:26306827
|
Sawant NS et al. |
Neuroleptic malignant syndrome in cycloserine-induced psychosis. |
2015 May-Jun |
Indian J Pharmacol |
pmid:26069374
|
Tandon VR et al. |
Cycloserine induced psychosis with hepatic dysfunction. |
2015 Mar-Apr |
Indian J Pharmacol |
pmid:25878391
|
Biswal I et al. |
Cedecea lapagei in a patient with malignancy: Report of a rare case. |
2015 Jul-Sep |
J Cancer Res Ther |
pmid:26458603
|
Lench AM et al. |
Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site. |
2015 |
PLoS ONE |
pmid:26193112
|